On Nov 18, 2021 Tavotek Biotherapeutics closed a Series B round and raised $35,000,000 from CS Capital, Fontus Capital, featuring lead investors CS Capital.
About the company: Tavotek Biotherapeutics is located at United States, North America.
Company website: http://www.tavotek.com